Chronic myelomonocytic leukemia: 2022 update on diagnosis, risk stratification, and management
MM Patnaik, A Tefferi - American journal of hematology, 2022 - Wiley Online Library
Abstract Disease Overview Chronic myelomonocytic leukemia (CMML) is a clonal
hematopoietic stem cell disorder with overlapping features of myelodysplastic syndromes …
hematopoietic stem cell disorder with overlapping features of myelodysplastic syndromes …
Definitions, Biology, and current therapeutic landscape of myelodysplastic/myeloproliferative neoplasms
MB Gerke, I Christodoulou, T Karantanos - Cancers, 2023 - mdpi.com
Simple Summary Myelodysplastic/myeloproliferative (MDS/MPN) neoplasms are blood
disorders characterized by abnormal cell growth and development. These disorders …
disorders characterized by abnormal cell growth and development. These disorders …
[HTML][HTML] How I diagnose and treat chronic myelomonocytic leukemia
MM Patnaik - Haematologica, 2022 - ncbi.nlm.nih.gov
Chronic myelomonocytic leukemia (CMML) is a myelodysplastic syndrome/
myeloproliferative overlap neoplasm characterized by sustained peripheral blood …
myeloproliferative overlap neoplasm characterized by sustained peripheral blood …
The mutational landscape in chronic myelomonocytic leukemia and its impact on allogeneic hematopoietic cell transplantation outcomes: a Center for Blood and …
M Mei, R Pillai, S Kim, N Estrada-Merly… - …, 2022 - pmc.ncbi.nlm.nih.gov
Somatic mutations are recognized as an important prognostic factor in chronic
myelomonocytic leukemia (CMML). However, limited data are available regarding their …
myelomonocytic leukemia (CMML). However, limited data are available regarding their …
Role of allogeneic transplantation in chronic myelomonocytic leukemia: an international collaborative analysis
M Robin, LC de Wreede, E Padron… - Blood, The Journal …, 2022 - ashpublications.org
To determine the survival benefit of allogeneic hematopoietic cell transplantation (allo-HCT)
in chronic myelomonocytic leukemias (CMML), we assembled a retrospective cohort of …
in chronic myelomonocytic leukemias (CMML), we assembled a retrospective cohort of …
Impact of a novel prognostic model on allogeneic hematopoietic stem cell transplantation outcomes in patients with CMML
JY Zhou, S Wang, HL Yuan, YJ Xu… - American Journal of …, 2023 - Wiley Online Library
Chronic myelomonocytic leukemia (CMML) is a clonal hematopoietic stem cell malignancy,
and allogeneic hematopoietic stem cell transplantation (allo‐HSCT) is the only curable …
and allogeneic hematopoietic stem cell transplantation (allo‐HSCT) is the only curable …
Risk-adapted, individualized treatment strategies of myelodysplastic syndromes (MDS) and chronic myelomonocytic leukemia (CMML)
JP Bewersdorf, AM Zeidan - Cancers, 2021 - mdpi.com
Simple Summary Myelodysplastic syndrome (MDS) and chronic myelomonocytic leukemia
(CMML) are two blood cancers with variable symptoms of low blood counts (fatigue …
(CMML) are two blood cancers with variable symptoms of low blood counts (fatigue …
Real-world data on chronic myelomonocytic leukemia: Clinical and molecular characteristics, treatment, emerging drugs, and patient outcomes
S Castaño-Díez, M López-Guerra, C Bosch-Castañeda… - Cancers, 2022 - mdpi.com
Simple Summary Chronic myelomonocytic leukemia (CMML) is an infrequent disease with
poor prognosis and risk of progression into acute myeloid leukemia (AML). Stem cell …
poor prognosis and risk of progression into acute myeloid leukemia (AML). Stem cell …
Genetic aspects of myelodysplastic/myeloproliferative neoplasms
Simple Summary Myelodysplastic/myeloproliferative neoplasms (MDS/MPN) are clonal
myeloid neoplasms characterized, at the time of their presentation, by the simultaneous …
myeloid neoplasms characterized, at the time of their presentation, by the simultaneous …
A multifactorial risk scoring system for the prediction of early relapse in CMML patients with allo-HSCT: a nationwide representative multicenter study
JY Zhou, YX Chen, HL Yuan, YJ Xu… - Bone Marrow …, 2024 - nature.com
Chronic myelomonocytic leukemia (CMML) is a clonal hematopoietic stem cell malignancy
and the only curable therapy is allogeneic hematopoietic stem cell transplantation (allo …
and the only curable therapy is allogeneic hematopoietic stem cell transplantation (allo …